Diagnosis and classification of eosinophilic fasciitis

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 379-382

  Pinal Fernandez, I ^a   Selva O' Callaghan, A ^a   Grau, J M ^b,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Eosinophilia; Eosinophilic fasciitis; Scleroderma like

Indexed keywords

CHEMICAL COMPOUND; CORTICOSTEROID; GADOLINIUM; GLUCOCORTICOID; METHOTREXATE; TOXIC SUBSTANCE;

AUTOIMMUNE DISEASE; CAPILLAROSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORTICOSTEROID THERAPY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; ECHOGRAPHY; EOSINOPHILIA; EOSINOPHILIC FASCIITIS; ERYTHEMA; FASCIA; FULL THICKNESS WEDGE BIOPSY; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; LABORATORY TEST; LEG SWELLING; MICROSTOMIA; MORPHEA; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; RAYNAUD PHENOMENON; REVIEW; RISK FACTOR; SCLERODERMA; SKIN BIOPSY; SOLID TUMOR; STANDARD; SYMPTOM; SYSTEMIC SCLEROSIS; TELANGIECTASIA;

EOSINOPHILIA; EOSINOPHILIC FASCIITIS; SCLERODERMA-LIKE;

ADRENAL CORTEX HORMONES; BIOPSY; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FASCIITIS; HUMANS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 84896316980     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.019     Document Type: Review

References (25)

1. Shulman L.E. Diffuse fasciitis with eosinophilia: a new syndrome?. Trans Assoc Am Physicians 1975, 88:70-86.
2. Lakhanpal S., Ginsburg W.W., Michet C.J., Doyle J.A., Moore S.B. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988, 17:221-231.
3. Lebeaux D., Frances C., Barete S., Wechsler B., Dubourg O., Renoux J., et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 2012, 51:557-561.
4. Endo Y., Tamura A., Matsushima Y., Iwasaki T., Hasegawa M., Nagai Y., et al. Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 2007, 26:1445-1451.
5. Bischoff L., Derk C.T. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 2008, 47:29-35.
6. Lebaux D., Sène D. Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 2012, 26:449-458.
7. Sullivan C., Coughlan R. Eosinophilic fasciitis in siblings. J Rheumatol 2013, 40:105.
8. Moore T.L., Zuckner J. Eosinophilic fasciitis. Semin Arthritis Rheum 1980, 9:228-235.
9. Jinnin M., Ihn H., Yamane K., Asano Y., Yazawa N., Tamaki K. Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis. Br J Dermatol 2004, 151:407-412.
10. French L.E., Shapiro M., Junkins-Hopkins J.M., Wolfe J.T., Rook A.H. Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa. J Am Acad Dermatol 2003, 49:1170-1174.
11. Toquet C., Hamidou M.A., Renaudin K., Jarry A., Foulc P., Barbarot S., et al. In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol 2003, 30:1811-1815.
12. Jinnin M., Ihn H., Yazawa N., Asano Y., Yamane K., Tamaki K. Circulating soluble CD40 ligand in patients with eosinophilic fasciitis. Ann Rheum Dis 2003, 62:190-191.
13. Daniel R.S., Lavery S., Maize J.C., Brown A.N., Bolster M.B. Unilateral eosinophilic fasciitis: an under-recognized subtype?. J Clin Rheumatol 2009, 15:247-249.
14. Trallero Araguas E., Selva O'Callaghan A., Simeon Aznar C.P., Sanjurjo Golpe E., Garcia-Patos V., Vilardell Tarres M. Eosinophilic fasciitis: analysis of a series of 10 patients. Med Clin (Barc) 2005, 125:145-148.
15. Serratrice G., Pellissier J.F., Roux H., Quilichini P. Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia. Muscle Nerve 1990, 13:385-395.
16. Moulin C., Cavailhes A., Balme B., Skowron F. Morphoea-like plaques revealing an eosinophilic (Shulman) fasciitis. Clin Exp Dermatol 2009, 34:e851-e853.
17. Killen J.W., Swift G.L., White R.J. Eosinophilic fasciitis with pulmonary and pleural involvement. Postgrad Med J 2000, 76:36-37.
18. Rizzo S. Eosinophilic pleuropericarditis and fasciitis. A new case. Monaldi Arch Chest Dis 2002, 57:311-313.
19. Kirschstein M., Helmchen U., Jensen R., Kuster R.M., Lehmann H. Kidney involvement in a 17-year-old boy with eosinophilic fasciitis. Clin Nephrol 1999, 52:183-187.
20. Herson S., Brechignac S., Piette J.C., Mouthon J.M., Coutellier A., Bletry O., et al. Capillary microscopy during eosinophilic fasciitis in 15 patients: distinction from systemic scleroderma. Am J Med 1990, 88:598-600.
21. Fujimoto M., Sato S., Ihn H., Kikuchi K., Yamada N., Takehara K. Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol 1995, 22:563-565.
22. Dybowski F., Neuen-Jacob E., Braun J. Eosinophilic fasciitis and myositis: use of imaging modalities for diagnosis and monitoring. Ann Rheum Dis 2008, 67:572-574.
23. Cheriet S., Chastan M., Levesque H., Marie I. Positron emission tomography in the diagnosis of eosinophilic fasciitis. QJM 2011, 104:987-988.
24. Antic M., Lautenschlager S., Itin P.H. Eosinophilic fasciitis 30years after-what do we really know? Report of 11 patients and review of the literature. Dermatology 2006, 213:93-101.
25. Bennett R.M., Herron A., Keogh L. Eosinophilic fasciitis. Case report and review of the literature. Ann Rheum Dis 1977, 36:354-359.